Christine E. Gray-Smith

CoTherix, Inc. develops therapeutic products. Its ventavis product is a nebulizer delivered therapy for pulmonary artery hypertension, which restricts blood flow to the lungs. CoTherix markets its products in the US, Europe, and Australia. The company was founded in February, 2000 by Donald J. Santel and Gerard Turino and is located in Brisbane, CA.

Triad Therapeutics was founded in April 1998 as Triad Biotechnology by scientists Stephen Coutts and Dan Sem and venture capitalist John Freund. In June 1999, Lin Yu and Rick Jack joined the Company as co-founders Triad Therapeutics, Inc. developed and manufactured drugs. It focused on generating highly potent and specific drug candidates by integrating structural biology, medicinal chemistry to accelerate discovery and development of potent, small molecule drugs. The company also provided high-affinity, nanomolar chemical lead compounds to pharmaceutical and biotechnology industries. It was founded in 1998 and was headquartered in San Diego, CA.

Part of ANI Pharmaceuticals, Inc., Calydon, Inc. develops therapeutic products for cancer. The company is based in Sunnyvale, CA. Calydon was acquired by Cell Genesys, Inc. on September 05, 2001 for $17.68 million.

Sugen, Inc. developed small molecule drugs and related pharmaceutical products. The company was founded on July 1, 1991 and was headquartered in New York, NY.

Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA.